Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Indication of the Parent Protocol
Dongjak Gu, Seoul
Indication of the Parent Protocol Clinical Trials in Dongjak Gu, Seoul
1 recruiting
Dongjak Gu, Seoul, South Korea
Showing
1–1
of
1
trials
Recruiting
Phase 3
Remibrutinib Open Label Roll-over Post-trial Access Protocol
Indication of the Parent Protocol
Novartis Pharmaceuticals
648 enrolled
33 locations
NCT07456891
Feedback